Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 1958 entries
View as:

A Study in Second Line Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01183780 Org: User:
Start: 12/02/10 End: 06/20/16 Due: 06/20/17

A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01697514 Org: User:
Start: 07/31/13 End: 07/31/16 Due: 07/31/17

A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT05327595 Org: User:
Start: 05/09/22 End: 04/22/24 Due: 04/22/25

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00190710 Org: User:
Start: 03/31/04 End: 08/31/07 Due: 08/31/08

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00384930 Org: User:
Start: 08/31/06 End: 10/31/08 Due: 10/31/09

A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06180954 Org: User:
Start: 09/23/20 End: 11/06/20 Due: 11/06/21

Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet

Phase: N/A Priority: Normal
NCT ID: NCT00324051 Org: User:
Start: 05/31/06 End: 09/30/07 Due: 09/30/08

A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02752087 Org: User:
Start: 04/30/16 End: 05/31/16 Due: 05/31/17

A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05338476 Org: User:
Start: 07/12/18 End: 09/18/18 Due: 09/18/19

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Phase: N/A Priority: Normal
NCT ID: NCT01017731 Org: User:
Start: 11/30/09 End: 05/31/14 Due: 05/31/15

A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03166124 Org: User:
Start: 05/24/17 End: 11/18/17 Due: 11/18/18

Study of LY3016859 in Participants With Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01774981 Org: User:
Start: 03/31/13 End: 08/31/15 Due: 08/31/16

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00700427 Org: User:
Start: 06/30/08 End: 10/31/13 Due: 10/31/14

A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00191412 Org: User:
Start: 01/31/05 End: 03/31/06 Due: 03/31/07

A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02248480 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT01458210 Org: User:
Start: 10/31/11 End: 02/29/12 Due: 02/28/13

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03435081 Org: User:
Start: 02/20/18 End: 08/16/21 Due: 08/16/22

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00486083 Org: User:
Start: 12/31/03 End: 10/31/04 Due: 10/31/05

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02857270 Org: User:
Start: 09/29/16 End: 10/24/22 Due: 10/24/23

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)

Phase: N/A Priority: Normal
NCT ID: NCT00910299 Org: User:
Start: 07/31/09 End: 04/30/11 Due: 04/30/12

A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT02109042 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

A Study of LY2801653 in Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01285037 Org: User:
Start: 09/09/09 End: 09/11/17 Due: 09/11/18

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Phase: N/A Priority: Normal
NCT ID: NCT00190814 Org: User:
Start: 09/30/03 End: 05/31/06 Due: 05/31/07

A Study for Participants With Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01025284 Org: User:
Start: 12/31/09 End: 07/31/12 Due: 07/31/13

A Study of LY3316531 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03611608 Org: User:
Start: 08/30/18 End: 03/15/19 Due: 03/15/20